AFAM Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
AFAM Capital's JNJ Position: Q3 2018 in Review
AFAM Capital increased its Johnson & Johnson (JNJ) stake by 1.3% in Q3 2018, buying an estimated $100K and bringing the position to 60,111 shares worth $8.3M. The position accounts for 1.16% of the portfolio, ranked #21.
AFAM Capital first reported a position in JNJ in Q1 2014 and has held it in 19 quarters since. The position peaked at $8.79M in Q4 2017. 2,583 funds tracked by Wall St. Rank hold JNJ as of Q3 2018.
- AFAM Capital held 60,111 shares of Johnson & Johnson worth $8.3M as of Q3 2018.
- AFAM Capital bought 754 Johnson & Johnson shares in Q3 2018, an estimated $100K.
- Johnson & Johnson made up 1.16% of AFAM Capital's portfolio in Q3 2018, its #21 holding.
- AFAM Capital first reported a position in Johnson & Johnson in Q1 2014 and has held it in 19 quarters since.
- AFAM Capital's Johnson & Johnson position peaked at $8.79M in Q4 2017.
- 2,583 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2018.
Based on AFAM Capital's 13F filing for Q3 2018, filed 14 Nov 2018.